Virbac shows 24% upside potential according to TP Icap
TP Icap Midcap analysts have attributed a 24% upside potential to Virbac shares versus current levels.
Published 4sem2 sources✓ Confirmedupdated 4sem
Lire en français
≈ 20s
The fact
This bullish recommendation is based on a positive fundamental valuation of the French veterinary laboratory.
Analyst consensus reflects growth prospects in the animal health sector.
2 sources — click a link to read an article on the topic: